Cargando…
Unraveling the Oncogenic Potential of VAV1 in Human Cancer: Lessons from Mouse Models
VAV1 is a hematopoietic signal transducer that possesses a GDP/GTP nucleotide exchange factor (GEF) that is tightly regulated by tyrosine phosphorylation, along with adapter protein domains, such as SH2 and SH3. Research on VAV1 has advanced over the years since its discovery as an in vitro activate...
Autores principales: | Shalom, Batel, Salaymeh, Yaser, Risling, Matan, Katzav, Shulamit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177506/ https://www.ncbi.nlm.nih.gov/pubmed/37174676 http://dx.doi.org/10.3390/cells12091276 |
Ejemplares similares
-
Vav1 Promotes B-Cell Lymphoma Development
por: Shalom, Batel, et al.
Publicado: (2022) -
Vav1 and mutant K-Ras synergize in the early development of pancreatic ductal adenocarcinoma in mice
por: Salaymeh, Yaser, et al.
Publicado: (2020) -
Vav1 mutations identified in human cancers give rise to different oncogenic phenotypes
por: Shalom, Batel, et al.
Publicado: (2018) -
Mutation of Vav1 adaptor region reveals a new oncogenic activation
por: Razanadrakoto, Lyra, et al.
Publicado: (2014) -
Vav1: A Dr. Jekyll and Mr. Hyde protein – good for the hematopoietic system, bad for cancer
por: Katzav, Shulamit
Publicado: (2015)